Free Trial

Charles River Laboratories International (CRL) Competitors

Charles River Laboratories International logo
$187.90 +1.80 (+0.97%)
(As of 11/20/2024 ET)

CRL vs. A, MTD, WAT, ILMN, TECH, BIO, BRKR, PACB, HBIO, and TMO

Should you be buying Charles River Laboratories International stock or one of its competitors? The main competitors of Charles River Laboratories International include Agilent Technologies (A), Mettler-Toledo International (MTD), Waters (WAT), Illumina (ILMN), Bio-Techne (TECH), Bio-Rad Laboratories (BIO), Bruker (BRKR), Pacific Biosciences of California (PACB), Harvard Bioscience (HBIO), and Thermo Fisher Scientific (TMO). These companies are all part of the "life sciences tools & services" industry.

Charles River Laboratories International vs.

Charles River Laboratories International (NYSE:CRL) and Agilent Technologies (NYSE:A) are both medical companies, but which is the better stock? We will compare the two businesses based on the strength of their valuation, dividends, risk, community ranking, profitability, analyst recommendations, media sentiment, earnings and institutional ownership.

Agilent Technologies has a net margin of 21.75% compared to Charles River Laboratories International's net margin of 10.44%. Agilent Technologies' return on equity of 25.26% beat Charles River Laboratories International's return on equity.

Company Net Margins Return on Equity Return on Assets
Charles River Laboratories International10.44% 14.29% 6.53%
Agilent Technologies 21.75%25.26%14.00%

Agilent Technologies received 369 more outperform votes than Charles River Laboratories International when rated by MarketBeat users. Likewise, 71.25% of users gave Agilent Technologies an outperform vote while only 60.32% of users gave Charles River Laboratories International an outperform vote.

CompanyUnderperformOutperform
Charles River Laboratories InternationalOutperform Votes
491
60.32%
Underperform Votes
323
39.68%
Agilent TechnologiesOutperform Votes
860
71.25%
Underperform Votes
347
28.75%

Agilent Technologies has higher revenue and earnings than Charles River Laboratories International. Charles River Laboratories International is trading at a lower price-to-earnings ratio than Agilent Technologies, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Charles River Laboratories International$4.13B2.33$474.62M$7.9923.52
Agilent Technologies$6.83B5.41$1.24B$4.8226.67

98.9% of Charles River Laboratories International shares are held by institutional investors. 1.3% of Charles River Laboratories International shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Charles River Laboratories International presently has a consensus target price of $214.38, indicating a potential upside of 14.10%. Agilent Technologies has a consensus target price of $144.36, indicating a potential upside of 12.28%. Given Charles River Laboratories International's higher possible upside, equities research analysts plainly believe Charles River Laboratories International is more favorable than Agilent Technologies.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Charles River Laboratories International
3 Sell rating(s)
10 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
1.93
Agilent Technologies
1 Sell rating(s)
5 Hold rating(s)
8 Buy rating(s)
0 Strong Buy rating(s)
2.50

In the previous week, Agilent Technologies had 6 more articles in the media than Charles River Laboratories International. MarketBeat recorded 20 mentions for Agilent Technologies and 14 mentions for Charles River Laboratories International. Agilent Technologies' average media sentiment score of 1.17 beat Charles River Laboratories International's score of 0.98 indicating that Agilent Technologies is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Charles River Laboratories International
10 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Positive
Agilent Technologies
12 Very Positive mention(s)
1 Positive mention(s)
7 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Charles River Laboratories International has a beta of 1.38, suggesting that its stock price is 38% more volatile than the S&P 500. Comparatively, Agilent Technologies has a beta of 1.07, suggesting that its stock price is 7% more volatile than the S&P 500.

Summary

Agilent Technologies beats Charles River Laboratories International on 13 of the 18 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

CRL vs. The Competition

MetricCharles River Laboratories InternationalCommercial physical research IndustryMedical SectorNYSE Exchange
Market Cap$9.61B$4.37B$5.05B$19.88B
Dividend YieldN/A1.63%5.17%3.54%
P/E Ratio23.5256.30123.8942.92
Price / Sales2.3359.581,181.4218.13
Price / Cash11.1725.6933.6617.85
Price / Book2.683.194.685.52
Net Income$474.62M$139.66M$119.38M$985.93M
7 Day Performance-9.02%-4.81%-2.46%-0.22%
1 Month Performance-4.99%14.86%-4.07%0.12%
1 Year Performance-1.38%30.64%29.77%23.70%

Charles River Laboratories International Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
CRL
Charles River Laboratories International
4.8024 of 5 stars
$187.90
+1.0%
$214.38
+14.1%
-1.4%$9.61B$4.13B23.5221,800Analyst Downgrade
A
Agilent Technologies
4.3924 of 5 stars
$130.00
+1.1%
$144.36
+11.0%
+12.8%$37.35B$6.83B26.6718,100Upcoming Earnings
News Coverage
Positive News
MTD
Mettler-Toledo International
4.1104 of 5 stars
$1,166.90
+0.5%
$1,338.75
+14.7%
+11.1%$24.62B$3.79B31.4617,300Positive News
WAT
Waters
4.1245 of 5 stars
$357.69
+3.8%
$365.85
+2.3%
+37.0%$21.24B$2.96B34.137,900
ILMN
Illumina
4.5866 of 5 stars
$131.94
+0.2%
$164.00
+24.3%
+34.9%$20.93B$4.50B0.009,300Positive News
TECH
Bio-Techne
4.8569 of 5 stars
$68.72
+3.5%
$81.78
+19.0%
+8.1%$10.92B$1.16B73.113,100
BIO
Bio-Rad Laboratories
4.7211 of 5 stars
$323.69
+0.9%
$391.80
+21.0%
+6.3%$9.06B$2.67B0.008,030Positive News
BRKR
Bruker
4.9986 of 5 stars
$53.79
+0.8%
$79.36
+47.5%
-12.9%$8.15B$2.96B25.669,707Dividend Announcement
Insider Trade
Gap Up
PACB
Pacific Biosciences of California
1.5162 of 5 stars
$1.74
+1.2%
$3.63
+108.3%
-80.0%$476.52M$200.52M0.00730Analyst Revision
HBIO
Harvard Bioscience
1.5634 of 5 stars
$2.16
+5.4%
N/A-48.8%$94.22M$112.25M-6.55490Positive News
TMO
Thermo Fisher Scientific
4.9906 of 5 stars
$512.86
+0.7%
$649.33
+26.6%
+9.3%$196.17B$42.86B32.15122,000Buyback Announcement
Positive News

Related Companies and Tools


This page (NYSE:CRL) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners